All stock lists
Galectin Therapeutics Inc (GALT)
United States · Delayed Price · Currency is USD
Healthcare
3.19+0.00 (+0.06%)
Insider Score
––Not scored
GALT Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
GALT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 1.85 M | 1.85 M | 1.43 M | 1.59 M | 1.36 M | — |
| R&D Expense | 2.13 M | 2.23 M | 1.93 M | 2.61 M | 3.26 M | — |
| Operating Expenses | 3.98 M | 4.08 M | 3.37 M | 4.20 M | 4.63 M | — |
| Operating Income | -3.98 M | -4.08 M | -3.37 M | -4.20 M | -4.63 M | — |
| Pretax Income | -9.11 M | -5.05 M | -5.50 M | -8.18 M | -7.52 M | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | -9.11 M | -5.05 M | -5.50 M | -8.18 M | -7.52 M | — |
| EPS (Basic) | -0.14 | -0.08 | — | -0.13 | -0.12 | -0.15 |
| EPS (Diluted) | -0.14 | -0.08 | — | -0.13 | -0.12 | -0.15 |
| Shares Outstanding | 65.88 M | 65.78 M | — | 64.20 M | 63.45 M | 63.20 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.